Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
209 words
A multiplicity of uniform batches of unit doses of a controlled, long-acting release pharmaceutical formulation, in oral tablet form, wherein each of said doses contains active therapeutic agent and a carrier base material, and wherein each of said unit doses has uniform bioavailability from batch to batch, said unit doses being prepared by a method comprising the steps of: (a) adding a quantity of solid, particulate carrier base material consisting essentially of at least one cellulosic ether selected from the group consisting of hydroxypropyl methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and ethyl cellulose, to a quantity of a therapeutically active pharmaceutical agent in granular or powder form; (b) mechanically mixing the carrier base material and the therapeutically active agent to form a uniform mixture; (c) discontinuing the mixing and permitting the mixture formed in step (a) to stand for a period of time from 2-27 hours to cause the therapeutically active pharmaceutical agent to become bonded to the carrier base material; and (d) compressing portions of the mixture formed in steps (b) and (c) into solid oral tablet doses, wherein release of said therapeutic agent from a unit dose of a given batch is substantially the same as release of said therapeutic agent from a unit dose of another batch.
Claim 2
Dependent Claim
209 words
A multiplicity of uniform batches of unit doses of a controlled, long-acting release pharmaceutical formulation, in oral tablet form, wherein each of said doses contains active therapeutic agent and a carrier base material, and wherein each of said unit doses has uniform bioavailability from batch to batch, said unit doses being prepared by a method comprising the steps of: (a) adding a quantity of solid, particulate carrier base material consisting essentially of at least one cellulosic ether selected from the group consisting of hydroxypropyl methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and ethyl cellulose, to a quantity of a therapeutically active pharmaceutical agent in granular or powder form; (b) mechanically mixing the carrier base material and the therapeutically active agent to form a uniform mixture; (c) discontinuing the mixing and permitting the mixture formed in step (a) to stand for a period of time from 2-27 hours to cause the therapeutically active pharmaceutical agent to become bonded to the carrier base material; and (d) compressing portions of the mixture formed in steps (b) and (c) into solid oral tablet doses, wherein release of said therapeutic agent from a unit dose of a given batch is substantially the same as release of said therapeutic agent from a unit dose of another batch.
Claim 3
Dependent Claim
36 words
A multiplicity of uniform batches of unit doses as recited in claim 1, wherein the mixture formed in step (b) is permitted to stand for at least 2 hours before compression into a unit dosage form.
Claim 4
Dependent Claim
140 words
A unit dosage form of a controlled, long-acting release pharmaceutical formulation wherein each of said unit dosages contains an active therapeutic agent and a carrier base material, and wherein each of said unit dosages has uniform bioavailability from batch to batch, said unit dosages being prepared by a method comprising the steps of: (a) thoroughly mixing a carrier base material comprising at least one cellulosic ether with a therapeutic agent to form a substantially uniform pharmaceutical formulation; (b) discontinuing the mixing step and permitting the mixture formed in step (a) to stand for a period of time sufficient to cause the said therapeutic agent to become bonded to the said cellulosic ether; and (c) compressing the said pharmaceutical formulation into a suitable unit dosage form wherein release, from batch to batch, is not faster, from one unit dosage to another.
Claim 5
Dependent Claim
140 words
A unit dosage form of a controlled, long-acting release pharmaceutical formulation wherein each of said unit dosages contains an active therapeutic agent and a carrier base material, and wherein each of said unit dosages has uniform bioavailability from batch to batch, said unit dosages being prepared by a method comprising the steps of: (a) thoroughly mixing a carrier base material comprising at least one cellulosic ether with a therapeutic agent to form a substantially uniform pharmaceutical formulation; (b) discontinuing the mixing step and permitting the mixture formed in step (a) to stand for a period of time sufficient to cause the said therapeutic agent to become bonded to the said cellulosic ether; and (c) compressing the said pharmaceutical formulation into a suitable unit dosage form wherein release, from batch to batch, is not faster, from one unit dosage to another.
Claim 6
Dependent Claim
24 words
A unit dosage form as recited in claim 3, wherein the carrier comprises one or more hydroxyalkyl cellulose or hydroxyalkyl alkylcellulose or derivatives thereof.
Claim 7
Dependent Claim
31 words
A unit dosage form as recited in claim 3, wherein the carrier comprises one or more of the cellulose ethers, hydroxypropyl methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and ethylcellulose or derivatives thereof.
Claim 8
Dependent Claim
32 words
A unit dosage form as recited in claim 3 wherein the mixture formed in step (a) is permitted to stand for at least 2 hours before compression into a unit dosage form.
Claim 9
Dependent Claim
17 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is isosorbide mononitrate.
Claim 10
Dependent Claim
17 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is isosorbide dinitrate.
Claim 11
Dependent Claim
16 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is theophylline.
Claim 12
Dependent Claim
16 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is nitroglycerin.
Claim 13
Dependent Claim
16 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is ibuprofen.
Claim 14
Dependent Claim
16 words
A unit dosage form, as recited in claim 3 wherein the active therapeutic agent is acetaminophe.